Default BP Medication Intensification

Summary

Default BP Medication Intensification is a clinical trial^[1].

Key Facts

• Default BP Medication Intensification is in the country of United States^[2].
• Default BP Medication Intensification's instance of is recorded as clinical trial^[3].
• Default BP Medication Intensification's start time is recorded as +2013-11-30T00:00:00Z^[4].
• Default BP Medication Intensification's end time is recorded as +2015-09-30T00:00:00Z^[5].
• Default BP Medication Intensification's sponsor is recorded as Cedars-Sinai Medical Center^[6].
• Default BP Medication Intensification's main subject is recorded as arterial hypertension^[7].
• Default BP Medication Intensification's number of participants is recorded as {'unit': '1', 'amount': '+3'}^[8].
• Default BP Medication Intensification's title is recorded as Automatic Medication Increase Protocol in the Treatment of Elevated Blood Pressure^[9].
• Default BP Medication Intensification's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Default BP Medication Intensification's ClinicalTrials.gov ID is recorded as NCT01994408^[11].
• Default BP Medication Intensification's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}^[12].
• Default BP Medication Intensification's clinical trial phase is recorded as phase I clinical trial^[13].
• Default BP Medication Intensification's clinical trial phase is recorded as phase II clinical trial^[14].
• Default BP Medication Intensification's research site is recorded as Cedars-Sinai Medical Center^[15].
• Default BP Medication Intensification's research subject recruitment status is recorded as terminated^[16].
• Default BP Medication Intensification's study type is recorded as interventional study^[17].